- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05419284
Feasibility of the Geriatric Activation Program Pellenberg With Caregiver Involvement
Feasibility of the Geriatric Activation Program Pellenberg With the Informal Caregiver as Exercise Partner of the Physiotherapist (GAPP+Care)
This interventional study aims to see if involving caregivers as exercise partners with the physiotherapist throughout in-hospital geriatric rehabilitation and the first six weeks following discharge is feasible.
Caregivers will receive hands-on training from physiotherapists so that they can assist their family members with their exercises. The caregivers will provide 30-minute exercise sessions three times each week in addition to the standard physiotherapy.
The researchers want to know how many people are eligible for GAPP+CARE and how willing they are to participate. The researchers also want to know about the program's hindering and facilitating elements, as well as its fidelity and retention rate. Apart from that, the researchers want to examine if an effectiveness study and the used outcome measures are viable.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To meet the WHO guideline for daily exercise during and after hospitalization, physiotherapists must find ways for geriatric patients to be active outside of therapy time. Geriatric patients require assistance or supervision to exercise safely, yet physiotherapists and nurses are short on time. Instead, by providing carers with tools and instruction, the researchers might turn them into exercise partners for the physiotherapist.
The investigators designed an exercise program (GAPP+Care) customized to the caregiver's ability to exercise safely with their loved one, based on the ideas and exercises of our standard physiotherapy program, the Geriatric Activation Program Pellenberg (GAPP). Through semi-structured interviews, patients and their caregivers were involved in developing and validating GAPP+Care, including the exercise booklet.
GAPP+Care consists of GAPP (the usual physiotherapy treatment) and three additional 30-minute exercise sessions with the caregiver each week (+Care). +Care will continue at home for the first six weeks after discharge, and GAPP will be replaced with physiotherapy performed by a private physiotherapist, as described at discharge (a prescription for home physiotherapy 3 times a week, for 60 sessions F-pathology or 18 sessions).
The initial +Care session is with a ward physiotherapist who will show the caregiver how to utilize the GAPP+Care handbook and the exercises and teach them how to support the patient during the exercises. During hospitalization, one of the three weekly sessions will be led by a ward physiotherapist to reinforce the hands-on skills and knowledge. These physiotherapy-patient-caregiver sessions will consist of two home visits and four phone calls after the patient has been discharged.
The goal of this exploratory study is to see if GAPP+Care is feasible. The researchers want to know how many people are eligible and how willing they are to participate. The researchers also want to assess the program's hindering and facilitating elements, as well as its fidelity and retention rate. Aside from that, the researchers want to evaluate if an effectiveness study and the used outcome measures are viable.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Margaretha van Dijk, Msc
- Phone Number: 0032332894
- Email: margaretha.vandijk@uzleuven.be
Study Locations
-
-
-
Pellenberg, Belgium, 3212
- Universitaire Ziekenhuizen Leuven, campus Pellenberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Patients:
Inclusion Criteria:
- Patients from geriatric rehabilitation unit, with various pathologies
- ≥ 70 years old
- ≥ 10m of walking with walking aid and under supervision
- Berg Balance Scale (BBS) < 30/56
- Medically stable as determined by the attending physician
- Expecting at least 3 weeks of rehabilitation
Exclusion Criteria:
- No available caregiver
- Unable to understand instructions
Caregivers:
Inclusion Criteria:
- A person who is willing to support the patient in performing exercises at least 3 times a week for 30 minutes. An informal carer is defined as an unpaid member of a person's social network who helps the patient with activities of daily living.
Exclusion Criteria:
- Physical unable to support the patient
- Unable to understand instructions
Healthcare providers
Inclusion Criteria:
- Someone who works on our ward, comes into contact with patients and may experience GAPP+CARE or its effects; nurse, physiotherapist, occupational therapist, social worker, doctor, logistical worker.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: patient
GAPP+Care
|
standard physiotherapy 45 minutes per day, 5 day a week (GAPP) + 3 extra exercise sessions led by a caregiver (+Care) |
Experimental: caregiver
+Care
|
3 extra exercise moments led by a caregiver: one physiotherapist-caregiver-patient exercise session: the physiotherapist will educate and train the caregiver on the exercises and hands-on skills. Two caregiver-patient exercise sessions |
Other: healthcare professional of the ward
observation of GAPP+Care
|
Healthcare workers in the geriatric rehabilitation ward will be interviewed on their opinions on GAPP+Care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of eligible individuals and their willingness to participate in GAPP+Care
Time Frame: 1 year
|
Number of available patients on the ward and number of eligible patients and caregivers and number of patients and caregivers who participate
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility, appropriateness, and the hindering and facilitating factors of GAPP+Care
Time Frame: patients and caregivers 2 times (at day of discharge and at the end of week 6 after discharge), healthcare providers 1 time (in the last 6 months of the study)
|
Semi-structured interviews with patients, caregivers and healthcare providers
|
patients and caregivers 2 times (at day of discharge and at the end of week 6 after discharge), healthcare providers 1 time (in the last 6 months of the study)
|
Fidelity to GAPP+Care
Time Frame: up to 12 weeks
|
Number of exercise moments with physiotherapist; Noted in exercise diary Number of exercise moments with caregiver; Exercise Diary Number and kind of exercises with caregiver; Exercise Diary
|
up to 12 weeks
|
Retention rate of participants
Time Frame: 1 year
|
Number of dropouts
|
1 year
|
Number of falls during the +Care sessions
Time Frame: up to 12 weeks
|
number of falls noted in the exercise diary or mentioned during the interviews
|
up to 12 weeks
|
Private physiotherapy after discharge
Time Frame: 6 weeks
|
number of sessions per week
|
6 weeks
|
Use of the activity monitor MOX, Maastricht Instruments
Time Frame: first week at baseline, first week after discharge (starting at day of discharge), and week 6 after discharge
|
measuring daily activity in minutes/24hours (sedentary - standing - dynamic)
|
first week at baseline, first week after discharge (starting at day of discharge), and week 6 after discharge
|
Functional balance
Time Frame: 3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at end of week 6 after discharge
|
Berg Balance Scale (BBS) 0-56, a higher score means a better outcome
|
3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at end of week 6 after discharge
|
Hand squeeze force
Time Frame: 3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at the end of week 6 after discharge
|
Maximum handgrip with dominant hand, measured with the Martin Vigory dynamometer, in kPa
|
3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at the end of week 6 after discharge
|
Walking speed
Time Frame: 3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at the end of week 6 after discharge
|
4m walking test (4mWT), m/s
|
3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at the end of week 6 after discharge
|
Quality of life patient and caregiver
Time Frame: 3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at end of week 6 after discharge
|
Visual analog scale of quality of life (VAS QoL), 0-10 a higher score means a better outcome
|
3 times over 10 weeks: baseline, at day of discharge (up tot 6 weeks after baseline) and at end of week 6 after discharge
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Johan Flamaing, PhD, MD, KU UZ Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S66154
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on GAPP+Care
-
Maastricht University Medical CenterMaastricht UniversityCompleted
-
Carlos III Health InstituteHealth Department of the Basque GovernmentCompleted
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
University of Lausanne HospitalsNational Heart, Lung, and Blood Institute (NHLBI); Swiss National Science FoundationCompletedPulmonary EmbolismSwitzerland, France, United States, Belgium
-
Johns Hopkins Bloomberg School of Public HealthRecruitingBreast CancerUnited States
-
University Hospital, BordeauxCompletedChronic Kidney DiseaseFrance
-
Kronikerenheden NordjyllandCompletedChronic Obstructive Pulmonary Disease (COPD)Denmark
-
Vanderbilt UniversityCompletedMidwifery | Prenatal Care | Maternal Health Services | Perinatal Care | Maternal-child Health ServicesUnited States
-
Him SACompletedHeart Failure | Stroke | Diabetes | COPD
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany